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What is known about the subject?
 ► Heart rate is crucial in evaluating the status of neo-
nates during resuscitation.
 ► Previous simulation studies and an animal model 
have shown that a smartphone application, NeoTap, 
offers fast and accurate heart rate monitoring.
 ► Clinical data on heart rate monitoring of neonates 
with a smartphone app are not yet available.
What this study adds?
 ► A smartphone application can improve speed and 
accuracy during heart rate assessment of neonates 
by auscultation in clinical setting.
 ► NeoTap could be a low- cost alternative to expensive 
medical equipment in both low- resource and high- 
resource settings.
AbstrACt
background Heart rate (HR) assessment is crucial 
in neonatal resuscitation, but pulse oximetry (PO) and 
electrocardiography (ECG) are rarely accessible in low- 
resource to middle- resource settings. This study evaluated 
a free- of- charge smartphone application, NeoTap, which 
records HR with a screen- tapping method bypassing 
mental arithmetic calculations.
Methods This observational study was carried out during 
three time periods between May 2015 and January 2019 
in Uganda in three phases. In phase 1, a metronome rate 
(n=180) was recorded by low- end users (midwives) using 
NeoTap. In phase 2, HR (n=69) in breathing neonates was 
recorded by high- end users (paediatricians) using NeoTap 
versus PO. In phase 3, HR (n=235) in non- breathing 
neonates was recorded by low- end users using NeoTap 
versus ECG.
results In high- end users the mean difference was 3 
beats per minute (bpm) higher with NeoTap versus PO 
(95% agreement limits −14 to 19 bpm), with acquisition 
time of 5 seconds. In low- end users, the mean difference 
was 6 bpm lower with NeoTap versus metronome (95% 
agreement limits −26 to 14 bpm) and 3 bpm higher with 
NeoTap versus ECG in non- breathing neonates (95% 
agreement limits −48 to 53 bpm), with acquisition time of 
2.7 seconds. The agreement between NeoTap and ECG was 
good in the HR categories of 60–99 bpm and ≥100 bpm; 
HR <60 bpm had few measurements (kappa index 0.71, 
95% CI 0.63 to 0.79).
Conclusion HR could be accurately and rapidly assessed 
using a smartphone application in breathing neonates 
in a low- resource setting. Clinical assessment by low- 
end users was less accurate with wider CI but still adds 
clinically important information in non- breathing neonates. 
The authors suggest low- end users may benefit from 
auscultation- focused training. More research is needed to 
evaluate its feasibility in clinical use.
IntroduCtIon
Neonatal deaths stand at 47% of all deaths in 
children <5 years of age, equal to 2.5 million 
neonates dying in 2017, with about 1 million 
dying on the first day.1 2 Intrapartum- related 
events (birth asphyxia) stand at around 
0.66 million deaths (uncertainty range of 
0.42–1.05 million).3 Moreover, 2.6 million 
stillbirths occur every year, 50% after the 
onset of labour.4 Successful resuscitation 
could prevent many early neonatal deaths and 
decrease the morbidity of neonates surviving 
asphyxia.5
Heart rate (HR) is one of the most important 
clinical parameters in evaluating the status of 
a neonate, to guide neonatal resuscitation 
and to predict early neonatal mortality and 
morbidity.6–8 International guidelines state 
that resuscitation efforts should be guided by 
checking respiration and HR.7 9 Pulse oxim-
etry (PO) is valuable in monitoring HR and 
measuring oxygen saturation,10 11 but HR is 
measured faster and more accurately through 
electrocardiography (ECG).7 9 Auscultation, 
recommended when PO and ECG are unavail-
able, is often inaccurate.12–16 Doppler is not 
recommended in current international guide-
lines.7 9 Resource- limited settings rarely have 
PO, ECG or Doppler.17 In 2017, a systematic 
review investigated the accuracy of seven new 
technologies for monitoring HRs of neonates 
and concluded that none could be recom-
mended as suitable for widespread clinical use 
at this stage.18 The need to develop a low- cost, 
rapid and accurate alternative method for 
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Figure 1 Tap to record the neonate’s heart rate by the NeoTap application. Heart rate <100 bpm (yellow) at 37 s: prepare for 
ventilation. Heart rate <60 bpm (red) at 2 min and 11 s: start chest compressions? Heart rate ≥100 bpm (green) at 3 min and 
37 s: neonatal resuscitation is going well. bpm, beats per minute.
monitoring HR during neonatal resuscitation has been 
highlighted.18 19
NeoTap (NeoTap Life Support- NeoTapLS) is a free- of- 
charge smartphone app for HR recording (Google Play 
and App Store), developed by a non- profit organisation 
(Tap4Life, Stockholm, Sweden).20 21 It uses a screen- 
tapping method; the user auscultates the heart sounds 
and taps the beat on the screen a minimum of three 
times, and the app generates a number, bypassing mental 
arithmetic (figure 1). No probes are needed, and the 
interface is functional even when protected inside a latex 
glove. The app can also be used to estimate cord pulsa-
tions and fetal HR; an instructional video on ‘How to 
use NeoTapLS’ is available in online supplementary file 
2 and the full version is available on YouTube. A signif-
icant proportion of health personnel in low- resource 
settings have their own smartphone, a number that is 
increasing.22 NeoTap has shown promising results from 
three simulation studies and an animal model.23–26
The aim of our study was to evaluate NeoTap by deter-
mining the speed and accuracy at which users could 
assess a rhythm by a metronome (low- end users, midwives 
well familiar with neonatal resuscitation but with no prior 
experience of the tapping method), HR in breathing 
neonates (high- end users, paediatricians well familiar 
with the tapping method), and HR in neonates in need 
of positive pressure ventilation (PPV), equal to neonates 
with insufficient or no breathing at birth (low- end users). 
The hypothesis was that NeoTap is as fast or faster than 




This prospective observational study was carried out 
during three time periods between May 2015 and January 
2019. It is a substudy of the ‘Randomized Clinical Trial 
Assessing Laryngeal Mask Airway Versus Face- Mask Venti-
lation in Neonatal Resuscitation (LMA vs FMV)’ ( Clini-
calTrials. gov NCT02042118) and the ‘Neonatal Resusci-
tation with Supraglottic Airway Trial (NeoSupra)’ ( Clin-
icalTrials. gov NCT03133572), conducted at the Depart-
ment of Obstetrics and Gynaecology, Mulago National 
Referral Hospital, Uganda, which has around 25 000 
deliveries per year.
data collection
The study had three phases to evaluate NeoTap by testing 
low- end users’ ability to tap a metronome rhythm and 
high- end and low- end users’ ability to tap a correct HR 
in clinical practice, as well as assess the swiftness of the 
method in clinical use. Low- end users in the first and third 
phases were research midwives and exposed on a daily 
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Figure 2 Low- end user using NeoTap to record heart rate 
(heart rate shown 147) and dry- electrode electrocardiography 
(heart rate shown 138). Picture used with written permission 
from the parents.
basis to neonatal resuscitation and trained according to 
Helping Babies Breathe, as part of the NeoSupra trial.27 
High- end users were two paediatric specialists. The users 
simultaneously tapped the pace of the rhythm of the 
metronome, or the HR they auscultated over the heart 
of the neonate, on the smartphone screen with the 
NeoTap app running. NeoTap is designed to display the 
average rate of the last three taps, meaning a number was 
displayed after a minimum of three taps (figure 2). The 
metronome was used as the true value in phase 1, HR by 
PO (PalmSAT 2500, Nonin Medical, Plymouth, USA) as 
the true value in phase 2 (no other monitoring equip-
ment was available at the time), and HR by ECG as the 
true value in phase 3. A convenience sample was chosen 
for each phase due to practical reasons and the explora-
tory nature of the study.
Phase 1: metronome rate by NeoTap (low-end users, a simulation)
In phase 1 we assessed the ability of low- end users to 
correctly record an audible metronome rhythm. Ten 
rates were randomly selected using a number generator 
set over the range of 20–150 beats per minute (bpm),28 
and the rates (masked to the participants) were presented 
by the metronome for approximately 20 s. Low- end users 
recorded the rate with the NeoTap, after first being intro-
duced to the app for 3–5 min, and wrote down the rate 
obtained on separate papers. The midwives included in 
the study were chosen irrespective of prior experience 
of smartphones. Informed consent was obtained from all 
participants.
Phase 2: HR by NeoTap versus PO (high-end users, healthy 
neonates)
In phase 2, we assessed the swiftness and ability of two 
high- end users to accurately record HR using NeoTap 
compared with PO in neonates not in need of PPV. PO 
was placed on the neonate on arrival on the resuscitation 
table by one high- end user and HR was assessed using 
NeoTap by the second high- end user as soon as HR was 
displayed by PO. Directly after HR was assessed using 
NeoTap, the second high- end user checked the HR on 
the PO (not masked to the participants) and noted both 
HRs on a paper. Acquisition time of NeoTap was noted 
(defined in seconds from start to end of tapping). Data 
were collected on- site when high- end users were avail-
able, and it was at this stage when it was unfeasible to 
involve low- end users since few were available. The first 
four paired HRs per neonate were collected. Informed 
consent was obtained from the parents on maternal 
admission and from the high- end users.
Phase 3: HR by NeoTap versus ECG (low-end users, neonates in 
need of PPV)
In phase 3, we assessed the swiftness and ability of low- end 
users to accurately record HR using NeoTap compared 
with ECG in neonates in need of PPV. ECG was placed 
on the neonate once feasible and HR was assessed using 
NeoTap when HR was displayed by ECG and compared 
with HR obtained by ECG at the same time (not masked 
to the participants). Low- end users were already intro-
duced to NeoTap in phase 1 and did not receive addi-
tional training prior to phase 3. The acquisition time of 
NeoTap was noted as in phase 2. No high- end users were 
available at the study site, and it was therefore not possible 
to include them. All resuscitations were video- recorded 
using an HD 1080P Black Box AI- IP018 camera (Shen-
zhen Aishine Electronics, China). The first 49 HR data 
were supervised by the researchers and collected on- site 
by traditional ECG (Philips Intellivue X2, Amsterdam, 
The Netherlands), and the rest were unsupervised and 
collected from video review with dry- electrode ECG 
(NeoBeat, Laerdal Global Health, Stavanger, Norway). 
All paired HRs (HR by NeoTap at the same time as HR by 
ECG) until end of resuscitation were collected; no upper 
limit was set for numbers of assessments per neonate 
(figure 2). All neonates lacking simultaneous data (only 
one device, poor signal acquisition or poor camera angle) 
were excluded (n=270). Data on Apgar and weight were 
double- entered using Android devices running the Open 
Data Kit V.2.0 tool suite.29 Written and oral information 
was given to all parents on maternal admission, and 
deferred consent was obtained post- hoc in cases needing 
resuscitation.27
Patient and public involvement
It was not appropriate to involve patients or the public 
in the design, or conduct, or reporting or dissemination 
plans for the study.
data analysis
The agreement in phase 1 was assessed using a Bland- 
Altman plot (including Pearson’s correlation coefficient 
between HR difference and HR values). The agreement 
in phase 2 and 3 was assessed using a Bland- Altman plot 
for repeated measures (including repeated measure 
correlation between HR difference and HR values), and 
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Figure 3 Agreement between the metronome rhythm and 
the rate low- end users recorded using NeoTap: a simulation. 
Metronome rhythm is shown on the x- axis and the difference 
from recordings done by NeoTap on the y- axis (Bland- Altman 
plot) (data set in online supplementary file). bpm, beats per 
minute.
Table 1 Characteristics of neonates in phase 2 and 3 of 
the study







In need of PPV No Yes
Apgar 1 min 9 (IQR 9–9) 3 (IQR 2–4)
Apgar 5 min 9 (IQR 9–10) 5 (IQR 4–6)










*Exact data on time for measurements not possible to obtain 
through the method used in phase 3.
HR, heart rate; PPV, positive pressure ventilation.
Figure 4 Agreement between NeoTap and pulse oximetry 
among high- end users recording heart rate in healthy 
breathing neonates. Pulse oximetry recording is shown on 
the x- axis and the difference between the readings on the 
y- axis (Bland- Altman plot) (data set in online supplementary 
file). bpm, beats per minute.
in phase 3 using repeated measures version of kappa 
index on the following HR categories: <60, 60–99 and 
≥100 bpm. The sensitivity and specificity of NeoTap in 
detecting bradycardia (HR <100 bpm) were also calcu-
lated. Acquisition times in phase 2 and 3 were summa-
rised with median and IQR for descriptive purposes. 
Statistical analysis was performed using R V.3.5 (R Foun-
dation for Statistical Computing, Vienna, Austria).30
results
During the three phases we had no issues with the reli-
ability of the app. The app is designed to use very low 
resources from the phone and is continuously updated. 
It never crashed and froze and no battery problems 
occurred. The quality of the videos in phase 3 was excel-
lent, with only a few exclusions due to non- visible HR on 
NeoTap or ECG.
Phase 1: metronome rate by neotap (low-end users, a 
simulation)
One hundred and eighty recordings were assessed by 18 
low- end users. There was a mean difference of −6 bpm 
with NeoTap versus metronome, with 95% agreement 
limits of −26 to 14 bpm (Bland- Altman plot) (figure 3). 
The difference was inversely correlated with the metro-
nome rhythm (r=−0.50, p<0.0001), moving from an over-
estimation to an underestimation. NeoTap recordings 
ranged from 21 to 131 bpm, and the metronome was set 
at a range of 30–130 bpm. In total 77% differed by 10 or 
less from the true value and 95% differed by 20 or less.
Phase 2: hr by neotap versus Po (high-end users, healthy 
neonates)
Sixty- nine HR recordings were assessed on 33 neonates 
as soon as HR by PO was available, which was at 120 s or 
more after birth (table 1). There was a mean difference 
of 3 bpm with NeoTap versus PO, with 95% agreement 
limits of −14 to 19 bpm (Bland- Altman plot) (figure 4). 
The difference was inversely correlated with HR (r=−0.43, 
p=0.009); it decreased, not towards a zero difference, but 
towards a negative difference. HR ranged from 132 to 214 
bpm with NeoTap, and from 126 to 205 bpm with PO. 
The median acquisition time for the estimated HR was 5 s 
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Figure 5 Agreement between NeoTap and ECG among 
low- end users recording heart rate in non- breathing neonates 
during neonatal resuscitation. ECG recordings are shown on 
the x- axis and the difference between the readings on the 
y- axis (Bland- Altman plot) (data set in online supplementary 
file). bpm, beats per minute; ECG, electrocardiography.
Table 2 Distribution in categories of correctly and 
incorrectly recorded heart rates among midwives assessing 
neonates in need of positive pressure ventilation compared 
with electrocardiography, phase 3
NeoTap Electrocardiography
<60 bpm 60–99 bpm ≥100 bpm
<60 bpm 1 1 0
60–99 bpm 2 22 8
≥100 bpm 0 4 197
Data expressed as number of evaluations in each category.
bpm, beats per minute.
(IQR 5–5), ranging from 3 to 15 s. In total, 88% differed 
by 10 or less from the true value and 96% differed by 20 
or less.
Phase 3: hr by neotap versus eCG (low-end users, neonates 
in need of PPV)
Two hundred and thirty- five HR recordings were assessed 
by approximately 18 low- end users on 98 neonates 
(table 1). There was a mean difference of 3 bpm with 
NeoTap versus ECG, with 95% agreement limits of −48 
to 53 bpm, a difference that did not correlate with HR 
(r=−0.06, p=0.51) (Bland- Altman plot) (figure 5). HR 
ranged from 46 to 294 bpm with NeoTap, and from 46 to 
229 bpm with ECG. The median acquisition time for the 
estimated HR was 2.7 s (IQR 1.7–4.7), ranging from 0.8 to 
13.9 s. When HR was evaluated using the categories <60, 
60–99 and ≥100 bpm (table 2), the agreement between 
NeoTap and ECG was good (kappa index 0.71, 95% CI 
0.63 to 0.79). The <60 bpm category included only three 
recordings, with NeoTap differing +3, –12 and −25 from 
ECG. The 60–99 bpm category included 27 recordings 
differing by a median of 7 (IQR 5–14) from the true 
value, and the >100 bpm category included 205 record-
ings differing by a median of 12 (IQR 5–24) from the 
true value. In total, 48% differed 10 or less from the true 
value and 73% differed by 20 or less. Overall, NeoTap 
showed very good sensitivity (0.87) and specificity (0.96) 
in detecting bradycardia (HR <100 bpm).
The complete data set for all three phases is available 
in online supplementary file.
dIsCussIon
This study presents new data on the feasibility of using a 
smartphone app for swift and accurate HR assessments 
in neonates, both those in need and not in need of PPV. 
NeoTap showed variable accuracy and precision in esti-
mating rates and HRs, especially in low- end users in 
HR auscultation. Low- end users could quickly learn the 
tapping technique and both high- end and low- end users 
were quick in estimating HRs.
In low- resource settings, neonatal resuscitation is 
mainly carried out by health personnel with limited 
experience in both airway management and ausculta-
tion. Reliable monitoring equipment is rarely available.17 
HR assessment is inaccurate due to imprecise ausculta-
tion and palpation or errors in mental arithmetic calcula-
tion.12–16 31 Auscultation is a three- step procedure: first is 
auscultating the heart, second is understanding what you 
hear (first and second heart sounds) and third is trans-
lating it by calculation to provide a number. A recent 
clinical study showed that HR auscultation by clinicians 
compared with PO and ECG was quick and reasonably 
accurate in neonates not in need of PPV. Still, studies 
during neonatal resuscitation with less experienced 
health personnel are lacking.32 Although imprecise, 
international guidelines recommend HR determination 
by physical examination if no PO and/or ECG are avail-
able.7 9
NeoTap over- rides the need for mental arithmetic 
calculations. In 2018, two simulation studies reported 
that HR could be accurately and rapidly assessed using 
NeoTap on a manikin.23 24 In 2019, another simulation 
study showed that NeoTap reduced the time to the first 
HR and the time to initiate heart compressions and to 
administer epinephrine compared with auscultation and 
mental computation.25 A porcine model showed that HR 
assessment with NeoTap had similar accuracy compared 
with auscultation with a digital stethoscope, ECG or 
carotid blood flow during asphyxia and faster acquisition 
time compared with the 6 s or 10 s method with a digital 
stethoscope.26 However, data on the clinically important 
group of HR <60 bpm are few and show contradictory 
results in the studies above as well as in the present study. 
A recent review on HR assessment stated that novel tech-
nologies including tap- based applications can support 
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HR assessment, but that their clinical efficacy during 
neonatal resuscitation has yet to be investigated.33
The accuracy in this study was highest among low- end 
users recording a metronome rhythm and in high- end 
users recording HR compared with PO in neonates not in 
need of PPV. In phase 1 there was an inverse correlation 
between the bpm presented and the difference—partic-
ipants overestimate low beats and underestimate high 
beats. We think this is because in low rates it is easy to tap 
too early and be too eager to tap the screen even when no 
sounds are presented, and in high rates it is hard to keep 
the high speed if you are not used to the tapping technic. 
In clinical use, this effect may be problematic in low HRs, 
but in high HRs it has minor clinical implications. Low- 
end users demonstrated the same mean difference in 
phase 3 as high- end users in phase 2, but with wider 95% 
agreement limits. Some recordings seemed to be twice 
the actual value. Health personnel, inexperienced in 
listening to hearts, may tap on both the first and second 
heart sounds, that is, tapping twice for each heart beat, 
a potential risk for errors in HR calculation even when 
auscultating without support from NeoTap. A qualitative 
study in our setting revealed that midwives did not assess 
HR by auscultation before the start of this study. Instead 
they palpated the cord or the chest.34 The midwives, 
however, accurately assessed the metronome rhythm. 
Auscultation- focused training and awareness of the first 
and second heart sounds could potentially improve clin-
ical HR assessment with the tapping method. Clinical 
studies have shown that training is crucial and repeated 
training of health personnel affects the management of 
patients.35 36 It is likely that clinicians would have obtained 
better results due to prior experience in HR auscultation, 
and a training module for HR auscultation in resuscita-
tion simulators could probably improve auscultation 
skills and performance of low- end users. Phase 3 shows 
few disagreements and narrow IQR ranges, and approx-
imately three- fourths of HRs differed 20 or less from the 
true value in the 60–99 bpm and ≥100 bpm categories, 
pointing at a high probability of adhering to guidelines.
There is need for a low- cost, rapid and accurate alterna-
tive method for monitoring HR during neonatal resusci-
tation in low- resource to middle- resource settings. Rapid 
and accurate decision- making is crucial in neonatal 
resuscitation and PO is too slow to fulfil international 
resuscitation guidelines.7 9 37 ECG is fast and accurate but 
may be difficult to apply on the wet torso of the neonate, 
leading to delayed application.38 39 NeoTap or other apps 
for HR assessment are potentially faster than PO and 
ECG, offering an alternative way to fulfil international 
guidelines.24 25 However, the reported acquisition times 
in phase 3 were possibly due to a misunderstanding of 
the ‘tap at least three times for HR’ feature of the app. 
Users should be reminded to tap until they feel confident 
of tapping the same pace as the HR they hear, still a swift 
method potentially leading to higher accuracy.
There are limitations to this study. Low- end users were 
skilled in neonatal resuscitation and were trained in 
Helping Babies Breathe shortly before the study started. 
The participants were part of an ongoing trial providing 
a better environment for auscultation. Less experienced 
healthcare providers in rural areas may produce inferior 
results. The gold standard is different for each of the 
three phases due to practical reasons, for example lack of 
ECG at the study site during phase 2. PO has high sensi-
tivity and specificity but may display a too low HR during 
the first minutes of life.40 PO in this study was used in 
neonates not in need of PPV at 120 s or more after birth, 
supporting the reliability of the PO data, and since 
NeoTap showed slightly higher HRs it points at NeoTap 
being accurate. The participants in phase 2 and 3 were 
not masked to the true value, introducing a potential 
bias, but the algorithm of NeoTap displays the average 
rate of the last three taps. This, combined with the very 
short acquisition times in both phases, de- emphasises this 
point. We had different users in the respective phases 
for practical reasons, making it harder to generalise the 
results. Most of the HR assessments in phase 3 were unsu-
pervised, meaning timing of placement of ECG and first 
HR assessment was up to the user. Also, in phase 3, we 
could not identify the users since only the hands were 
caught on the videos; therefore, the number of users 
in this phase is an approximation. Lastly, we had few 
measurements of HR <100 bpm and especially <60 bpm, 
limiting the possibility of evaluating the importance of 
the results in clinical practice.
ConClusIon
NeoTap provides a low- cost technology well adapted to 
the context of low- resource settings. It can be used in 
an inexpensive smartphone for swift and accurate HR 
registration. Clinical assessment by low- end users was less 
accurate and the authors suggest they may benefit from 
auscultation- focused training. Further studies are needed 
to demonstrate whether smartphone apps are useful in 
clinical practice.
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